SB-612111 是一种新型高效的人阿片受体孤儿受体 (ORL-1) 拮抗剂,对 hORL-1 具有较高的亲和力 (Ki=0.33 nM)。SB-612111 对 μ-,κ- 和 δ-receptor 的 Ki 值分别为 57.6 nM,160.5 nM 和 2109 nM。SB-612111 能有效拮抗 Nociceptin 在急性疼痛模型中的造成的痛觉作用。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
SB-612111 is a novel and potent human opiate receptor-like orphan receptor (ORL-1) antagonist with a high affinity for hORL-1 (Ki=0.33 nM). SB-612111 exhibits selectivity for μ-, κ- and δ-receptors with Ki values of 57.6 nM, 160.5 nM and 2109 nM, respecticely. SB-612111 effectively antagonizes the pronociceptive action of Nociceptin in an acute pain model[1].
[1]. Paola F Zaratin, et al. Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111).J Pharmacol Exp Ther. 2004 Feb;308(2):454-61.
(5R,6E)-5-Hydroxy-1,7-diphenyl-6-hepten-3-one
¥1080.00 ¥1350.00
PtdIns-(4,5)-P2-fluorescein (ammonium salt)
¥1140.00 ¥1425.00
2'-O-Monosuccinyladenosine-3',5'-cyclic monophosphate
¥980.00 ¥1225.00
没有评价数据